In this article, Ben Hargreaves asks whether there is particular potential for the technologies to revolutionise staff training and reduce costs in pharma manufacturing. Virtual reality (VR ...

boosting their US manufacturing presence to avoid a potential 25% tariff on imported pharma products. Although World Trade Organization rules exempt most pharmaceuticals and their starting ...

along with the time and cost investments required for technology transfer to manufacturing facilities, presents additional hurdles. In Tokyo, Astellas Pharma shares were trading at 1,481.00 yen ...